NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 1 percent decline in its second quarter revenues but still beat analysts' average estimate. 

For the three months ended June 27, the firm posted $4.27 billion in revenues, down from $4.32 billion from the year-ago quarter but above the consensus Wall Street estimate of $4.17 billion.

Thermo Fisher said that its organic revenue growth was 6 percent. The firm said that divestitures, net of acquisitions, decreased its revenue by 1 percent in the quarter and currency translation reduced revenue by 6 percent. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.